It has been suggested that CatD is also involved in the proteolysis of both lipid‐free recombinant full‐length human apolipoprotein E (apoE) and lipidated human plasma full‐length apoE4 into toxic peptide, contributing to the progression of AD [263]. The gene discussed is APOE; the disease is Alzheimer disease.